Allarity provides 2024 corporate update
PremiumThe FlyAllarity provides 2024 corporate update
1M ago
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
Premium
Press Releases
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
1M ago
Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity
Premium
Company Announcements
Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity
2M ago
Allarity Therapeutics Signs New Management Services Agreement
PremiumCompany AnnouncementsAllarity Therapeutics Signs New Management Services Agreement
3M ago
Allarity regains compliance with Nasdaq minimum stockholder equity requirement
Premium
The Fly
Allarity regains compliance with Nasdaq minimum stockholder equity requirement
3M ago
Allarity Therapeutics Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
Premium
Press Releases
Allarity Therapeutics Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
3M ago
Allarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing
PremiumCompany AnnouncementsAllarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing
4M ago
Allarity exceeds Nasdaq’s minimum equity requirement
Premium
The Fly
Allarity exceeds Nasdaq’s minimum equity requirement
4M ago
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
Premium
Press Releases
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100